Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.

Rosner MH, Dalkin AC.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1722-9. doi: 10.2215/CJN.02470312. Epub 2012 Aug 9. Review.

2.

Hypercalcemia and bone resorption in malignancy.

Walls J, Bundred N, Howell A.

Clin Orthop Relat Res. 1995 Mar;(312):51-63. Review.

PMID:
7634618
3.

Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.

Wysolmerski JJ, Broadus AE.

Annu Rev Med. 1994;45:189-200. Review.

PMID:
8198376
4.

[Refractory hypercalcemia in patient with lung cancer].

Grzywacz A, Dziuk M, Niemczyk S.

Pol Merkur Lekarski. 2014 Apr;36(214):261-4. Polish.

PMID:
24868900
5.

Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.

Reagan P, Pani A, Rosner MH.

Am J Kidney Dis. 2014 Jan;63(1):141-7. doi: 10.1053/j.ajkd.2013.06.025. Epub 2013 Sep 8.

PMID:
24021907
6.

Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.

Kovacs CS, MacDonald SM, Chik CL, Bruera E.

J Pain Symptom Manage. 1995 Apr;10(3):224-32. Review.

PMID:
7543127
7.

[Hypercalcemia of malignancy: clinical features, diagnosis and treatment].

Farias ML.

Arq Bras Endocrinol Metabol. 2005 Oct;49(5):816-24. Epub 2006 Jan 23. Review. Portuguese.

8.

Emergency Management of Malignancy-Associated Hypercalcemia.

Dellay B, Groth M.

Adv Emerg Nurs J. 2016 Jan-Mar;38(1):15-25; quiz E1. doi: 10.1097/TME.0000000000000093. Review.

PMID:
26817427
9.

Mechanisms and treatment of hypercalcemia of malignancy.

Clines GA.

Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):339-46. doi: 10.1097/MED.0b013e32834b4401. Review.

PMID:
21897221
10.

Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.

Mosekilde L, Eriksen EF, Charles P.

Crit Rev Oncol Hematol. 1991;11(1):1-27. Review.

PMID:
1883526
11.

Mechanisms of cancer-induced hypercalcemia.

Rosol TJ, Capen CC.

Lab Invest. 1992 Dec;67(6):680-702. Review.

PMID:
1460860
12.

[Progress in therapy and diagnosis: Hypercalcemia due to parathyroid hormone-related protein producing neoplasms].

Tanaka Y, Okada Y.

Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):669-74. Review. Japanese. No abstract available.

PMID:
17506302
13.

Onco-nephrology: glomerular diseases with cancer.

Cambier JF, Ronco P.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1701-12. doi: 10.2215/CJN.03770412. Epub 2012 Aug 16. Review.

14.

[Pathophysiology and treatment of malignancy-associated hypercalcemia].

Miyauchi A.

Nihon Rinsho. 2006 Jun 28;Suppl 2:161-4. Review. Japanese. No abstract available.

PMID:
16817374
15.

[Treatment of malignancy associated hypercalcemia].

Tai N, Inoue D.

Clin Calcium. 2014 Aug;24(8):1223-8. doi: CliCa140812231228. Review. Japanese.

PMID:
25065875
16.

Incidence and pathophysiology of hypercalcemia.

Mundy GR.

Calcif Tissue Int. 1990;46 Suppl:S3-10. Review.

PMID:
2105829
17.

Current management strategies for hypercalcemia.

Pecherstorfer M, Brenner K, Zojer N.

Treat Endocrinol. 2003;2(4):273-92. Review.

PMID:
15966562
18.

Paraneoplastic hypercalcemia in gynecologic malignancy.

Holtz G.

Obstet Gynecol Surv. 1980 Mar;35(3):129-36. Review. No abstract available.

PMID:
6987579
19.

Pathophysiology and management of severe hypercalcemia.

Nussbaum SR.

Endocrinol Metab Clin North Am. 1993 Jun;22(2):343-62. Review.

PMID:
8325291
20.

[Medical treatment of malignant hypercalcemia].

Eto S, Nakano Y, Okada Y.

Gan To Kagaku Ryoho. 1993 Dec;20(15):2311-8. Review. Japanese.

PMID:
8259844

Supplemental Content

Support Center